05-12 Organigram Global Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2026 CI
05-12 Organigram Global Inc. Updates Revenue Guidance for the Fiscal Year 2026 CI
05-12 Organigram Global Inc. Reports Impairment of Property, Plant and Equipment, Intangible Assets and Goodwill for the Second Quarter Ended March 31, 2026 CI
05-12 Organigram Global : INVESTOR PRESENTATION (dad9ab a7f6d4c8) PU
05-12 Organigram Global Inc., Q2 2026 Earnings Call, May 12, 2026
05-12 OrganiGram: Fiscal Q2 Earnings Snapshot AQ
05-12 Organigram Global Swings to Q2 Net Loss, Net Revenue Falls; Updates Fiscal 2026 Guidance MT
05-12 Organigram Global : Press Release (dad9ab a96f5298) PU
05-12 Earnings Flash (OGI) Organigram Global Inc. Reports Q2 Net Loss $0.9M Vs Net Income of $42.5M in Q2 Fiscal 2025 MT
05-12 Organigram Q2 Adjusted EBITDA $0.9M, Down 82% YoY MT
05-12 Organigram Q2 Net Revenue $59.8M, Down 9% YoY MT
05-12 Organigram Reports Second Quarter Fiscal 2026 Results BU
05-06 Organigram to Report Second Quarter Fiscal 2026 Results on May 12th, 2026 BU
04-15 Organigram Global Inc. announced that it has received CAD 65.200001 million in funding from BT DE Investments Inc. CI
04-15 Organigram Closes the 107.3-Million Acquisition of Germany's Sanity Group MT
04-15 Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities BU
04-15 Organigram Closes Senior Secured Credit Facilities CI
04-15 Organigram Global Inc. Appoints Max Konrad Narr to the Board of Directors CI
04-14 Organigram Global Inc. announced that it has received CAD 65.200001 million in funding from BT DE Investments Inc. CI
04-14 Organigram Global Inc. completed the acquisition of remaining 91% stake in The Sanity Group GmbH from BT DE Investments Inc. and others for approximately ?220 million. CI
03-31 Organigram Announced Shareholder Approval of Acquisition of Sanity Group GmbH MT
03-30 Organigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting BU
03-30 Organigram Global Inc. - Shareholder/Analyst Call
03-23 Organigram Says Proxy Firm ISS Recommends Approval of Sanity Group Acquisition MT
03-23 Organigram Brief: ISS Citing "Compelling Strategic Rationale, Favorable Market Reaction, and Strong Institutional Confidence" in Recommending Shareholders Vote FOR the Transaction Resolution MT
No results match your criteria
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!